We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 17

EU Commission proposal on counterfeit drugs
  • Gowling WLG
  • European Union
  • March 4 2009

The EU Commission released its proposal in December 2008 designed to deal with the issue of counterfeit drugs.


The Pharmaceutical Sector Inquiry Preliminary Report: patent-related issues raised relevant to all patent intensive industries
  • Gowling WLG
  • United Kingdom, European Union
  • January 29 2009

Wragge & Co's first analysis of the EU Commission's preliminary report on the pharmaceutical sector looked at the regulatory issues covered by the preliminary report.


Investigation of competition law infringements; what powers do the competition authorities have to conduct a search in my home?
  • Gowling WLG
  • United Kingdom, European Union
  • November 13 2008

As today's headlines show, there's yet more evidence that the competition authorities will stop at nothing to bring the perpetrators of anti-competitive behaviour to justice.


Implemention of “Bolar” in the EU
  • Gowling WLG
  • United Kingdom, European Union
  • October 31 2007

In Europe, Directive 200427EC (amending Directive 200183EC) introduced into European Union legislation for the first time an exemption from patent infringement for conducting certain developmental work pre-patent expiry (the EU ‘Bolar’ exemption).


Scott E. Foster
  • Gowling WLG


Scott Robertson
  • Gowling WLG

Alice Stagg
  • Gowling WLG

Wendy J. Wagner
  • Gowling WLG